Absent T Lymphocytes

Search Trials
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
Status:
Active, not recruiting
Last Changed:
Oct 5, 2020
First Changed:
Oct 4, 2017
Disease(s):
Acute Lymphoblastic Leukemia
Intervention(s):
BPX-501 T cellsAP1903
Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant
Status:
Active, not recruiting
Last Changed:
Nov 17, 2020
First Changed:
Feb 19, 2014
Disease(s):
Acute Lymphoblastic Leukemia
Intervention(s):
BPX-501 T cellsrimiducid
Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant
Status:
Completed
Last Changed:
Mar 7, 2017
First Changed:
Dec 7, 2006
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
lithium carbonatelaboratory biomarker analysis
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
Status:
Completed
Last Changed:
May 23, 2017
First Changed:
Nov 21, 2008
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
ondansetronsurvey administrationmanagement of therapy complications
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
Status:
Completed
Last Changed:
Apr 29, 2014
First Changed:
Nov 1, 2010
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
Akt inhibitor MK2206diagnostic laboratory biomarker analysispharmacological study

Connect. Empower. Inspire.